SPINK9 binds KLK5

Stable Identifier
R-HSA-8850818
Type
Reaction [binding]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Extracellular SPINK9 (Serine protease inhibitor Kazal-type 6) binds KLK5 (kallekrein-related peptidase 5), inactivating the latter. KLK5 activity contributes to the process of desquamation, and SPINK9 binding may play a role in the regulation of that process (Brattsand et al. 2009; Meyer-Hoffert et al. 2009).

Literature References
PubMed ID Title Journal Year
19194479 SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor

Brattsand, M, Stefansson, K, Hubiche, T, Nilsson, SK, Egelrud, T

J. Invest. Dermatol. 2009
19190773 Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor

Meyer-Hoffert, U, Wu, Z, Schröder, JM

PLoS ONE 2009
Participants
Participant Of
Orthologous Events
Authored
Reviewed
Created